Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Wants only an approved medicine
Among non-elderly adults with ESI (estimated to be 116.8 million from NHIS), 42%, or 49.3 million people, are clinically eligible for GLP-1 drugs
Heath et al
These side effects include: Itchiness, redness at the site of injection Dizziness or headaches Increased heart rate (mild tachycardia) Infections More serious complications are also possible, such as pancreatitis, intestinal or bowel blockages, and gastroparesis
Semin Neurol 36:288297 Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J et al (2017) Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial
US$ 28.35
US$ 23.64
US$ 22.85
US$ 22.62
US$ 20.45
US$ 26.85
US$ 27.29
